ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2016

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.

D Pouessel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.